Biodesix, Inc. BDSX
Set alert
21.37 USD -0.41 -1.88%
As of Nov 3, 11:57 AM ET
21.20 Day range 22.89
5.26 52-week range 31.97
- YTD
- +214.26%
- 1 year
- +237.07%
- Open
- 21.80
- Prev close
- 21.78
- Mkt cap
- 223.68M
- Vol
- 12.19K
- Avg vol
- 104.41K
- EPS
- -3.10
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 21.20
- High
- 22.89
- Forward P/E
- -6.64
- Beta
- 1.21
- Short ratio
- 0.83
- Inst. own
- 42.83%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.43
- 200-d avg
- 1.53
- 1y target
- 3.10
Analyst view
Price target (mean) 3.10 -85.5% downside
Now 21.37
- Target (low)
- 3.00
- Target (mean)
- 3.10
- Target (high)
- 3.50
Ratings (0m) 6 6 buy · 0 hold · 0 sell
- Strong buy1
- Buy5
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 19.83M | +35.2% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 20.22M | +36.5% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 70.73M | +44.1% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 92.25M | +30.4% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 16, 2024 | Scotiabank | Initiated | — | Sector Outperform |
| Jul 26, 2024 | Craig-Hallum | Initiated | — | Buy |
| May 13, 2024 | TD Cowen | Initiated | — | Buy |
| May 3, 2024 | Lake Street | Initiated | — | Buy |
| Mar 4, 2024 | Canaccord Genuity | Reiterated | Buy | Buy |
| Dec 7, 2023 | Canaccord Genuity | Reiterated | Buy | Buy |
| May 12, 2022 | Morgan Stanley | Maintained | — | Equal-Weight |
| Apr 20, 2022 | Cowen & Co. | Initiated | — | Outperform |
| Nov 17, 2021 | Morgan Stanley | Downgrade | Overweight | Equal-Weight |
| May 12, 2021 | Morgan Stanley | Maintained | — | Overweight |
| Mar 18, 2021 | Morgan Stanley | Maintained | — | Overweight |
| Feb 2, 2021 | Canaccord Genuity | Maintained | — | Buy |
| Nov 23, 2020 | William Blair | Initiated | — | Outperform |
| Nov 23, 2020 | BTIG | Initiated | — | Buy |
| Nov 23, 2020 | Morgan Stanley | Initiated | — | Overweight |